We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lawsuit Accuses Gilead of Sitting on Safer HIV Drugs to Maximize Profit
Lawsuit Accuses Gilead of Sitting on Safer HIV Drugs to Maximize Profit
A federal lawsuit accuses Gilead of deliberately keeping a safer version of its HIV drug Tenofovir disoproxil fumarate (TDF) off the market until patent exclusivity ends for the original.